Chemistry: analytical and immunological testing – Involving producing or treating antigen or hapten
Patent
1995-01-19
2000-01-04
Duffy, Patricia A.
Chemistry: analytical and immunological testing
Involving producing or treating antigen or hapten
436544, 436545, 436546, 530300, 530324, A61K 3800
Patent
active
060109130
ABSTRACT:
The invention deals with isolated human tau peptide epitopes of SEQ ID Nos: 1 to 4, 7 and 15 to 20 which have the capability of binding AT120 monoclonal antibody.
REFERENCES:
Copy of European Search Report (2 pages).
Copy of International (PCT) Search Report (3 pages).
Copy of EMBO Journal vol. 8, No. 2, pp. 393-399 1989.
Copy of Proc, Natl.Acad. Sci. USA vol. 88, pp. 4543-4547 May 1991.
Vandermeeren et al, Journal of Neurochemistry, 61:1828-1834, 1993.
Mercken et al, Acta Neuropathol, 84:265-272, 1992.
Ksiezak-Reding et al, J. Neurosci Res, 25(3):420-430, 1990.
Bron et al, Biochem J. 273(1):127-133, 1991.
Mercken Marc
Van De Voorde Andre
Vandermeeren Marc
Vanmechelen Eugeen
Duffy Patricia A.
N.V. Innogenetics S.A.
LandOfFree
Isolated human tau peptide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated human tau peptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated human tau peptide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1072087